Syndax Pharmaceuticals, Inc.
SNDX
$24.00
$0.502.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.77% | 27.83% | -5.56% | -17.19% | -29.94% |
| Total Depreciation and Amortization | -- | 50.00% | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -103.33% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.50% | 47.14% | 65.63% | 31.57% | 87.15% |
| Change in Net Operating Assets | -143.25% | -285.09% | -165.54% | -5.81% | 4.52% |
| Cash from Operations | -21.08% | -13.18% | -22.54% | -13.90% | -38.79% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.35% | -16.45% | -32.17% | 194.71% | -1,551.15% |
| Cash from Investing | 130.33% | -16.60% | -32.17% | 194.71% | -1,551.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 56.82% | 102.65% | -18.49% | -57.10% | -98.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.30% | 102.65% | -18.49% | -57.10% | 34.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.51% | -70.42% | -391.99% | 99.95% | -89.51% |